VRKSX Mutual Fund

NAV$10.16

Fund Essentials - as of Mar 31, 2026

Net Assets
$4M
Expense Ratio
0.89%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••

Performance

YTD+2.52%
1 Year-6.71%
3 Year+3.88%
5 Year-0.36%

Asset Allocation

Stocks: 99.17%
Cash: 0.83%

Top Holdings

View All →
TickerNameWeight
LMATLemaitre Vascular Inc5.91%
HEI.AHeico Corp. Cl. A4.92%
WSTWest Pharmaceutical Services Inc4.92%
TDYTeledyne Technologies Inc4.86%
HQYHealthequity4.31%
Top 10 Concentration: 44.02%Report Date: Mar 31, 2026
Download all 28 holdings for VRKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

VRKSX Mutual Fund Overview

VRKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class R6) is managed by Virtus Investment Partners with $4.2M in net assets. VRKSX expense ratio is 0.89%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VRKSX performance shows a YTD return of 2.52%. The 1-year return is -6.71% and the 5-year return is -0.36%.

VRKSX top holdings include Lemaitre Vascular Inc (5.9%), Heico Corp. Cl. A (4.9%), West Pharmaceutical Services Inc (4.9%), Teledyne Technologies Inc (4.9%), Healthequity (4.3%). View all VRKSX holdings, sector breakdown, or dividend history.

VRKSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VRKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.